What You Should Know:
– OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round led by Celesta Capital, with participation from Tenacity Ventures, Cedars…
Continue Reading
AI technology is being rolled out at seven NHS trusts within the Greater Manchester Imaging Network to help doctors detect diseases, including lung cancer, quicker.
The solution from global health tech firm Annalise.ai uses AI-powered…
What You Should Know:
–Reimagine Care, the nation’s leading on-demand cancer care provider, today announced an expansion of its innovative symptom-management program to now support surgical oncology patients, transforming the experience of post-operative cancer care.
– Global…
Continue Reading
We developed an interpretable model, BOUND (Bayesian netwOrk for large-scale lUng caNcer Digital prescreening), using a comprehensive EHR dataset from the China to improve lung cancer detection rates. BOUND employs Bayesian network uncertainty inference,…
Continue Reading
Introduction
Seno Medical Imagio Breast Imaging System has achieved a significant milestone by receiving an Innovative Technology contract from Vizient, Inc., the nation’s largest healthcare performance improvement organization. This recognition underscores the Imagio System’s potential…
Lunit collabs with AstraZeneca, secures major deal in France Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims…
Special thanks to Jimmy Niggles for raising awareness about the dangers of melanoma and for highlighting the valuable role My Health Record can play in storing vital health information.Social media links:LinkedIn: https://www.linkedin.com/company/australian-digital-health-agencyFacebook: https://www.facebook.com/AuDigitalHealthTwitter: https://twitter.com/AuDigitalHealthVideo…
Continue Reading
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.According to a press statement, the following organisations will…
Continue Reading
What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
